BioSyft published new work from close collaborator David Marcus and colleagues in Nature regarding endocannabinoid signaling regulating reward-seeking behavior and identifying a thalamo-striatal circuit.

Mission: To make discoveries about the brain, through innovations in behavior, for better models, novel treatments, and a healthier society. Revolutionizing Animal Research: Animal model research is overdue for a technological leap. BioSyft offers a cutting-edge solution that modernizes rodent studies, which make up 95% of all animal research, advancing drug discovery and maximizing animal's contribution to science. The Problem: Current methods for animal tracking are limited to manual monitoring or outdated technologies which are biased, labor-intensive, and inconsistent. Most labs lack the tools to produce reliable, high-quality data, undermining animal research's potential and reducing the value of animal studies entirely. This problem is increasingly relevant in regards to brain disorders which are DEPENDENT on studying complex animal models. Our Solution: BioSyft has developed a breakthrough system combining computer vision and predictive analysis, designed by expert behavioral neuroscientists. Tracking 25+ spatial points (compared to the standard 3), our platform automates analysis, reduces bias, and standardizes data collection. Validated in the most commonly used rodent strain, our technology promises to transform and elevate animal model research for drug discovery and development for brain disorders.